On the issue of assessing the quality of preservatives used in current practice of immunobiological preparations production

The analysis of national and foreign normative documents regulating modern requirements for preservative quality assessment has been performed. The need for elaboration of modern requirements for quality assessment and standardization of preservatives used in the production of immunobiological preparation in accordance with the good manufacturing and laboratory practice (GMP and GLP) has been justified. The conducted analysis has shown that the most common preservatives in immunobiological preparations are thiomersal, phenol and formaldehyde. The requirements for these preservatives have been elaborated and systematized. International and national assay methods and requirements for thiomersal, phenol, formaldehyde, have been characterized. The results of the studies have been used in elaboration of general chapters related to the assay of thiomersal, phenol and formaldehyde in immunobiological preparations. The projects of general chapters have been approved the minutes of the Board of the Ministry of Health of the Russian Federation on the State Pharmacopoeia and proposed for inclusion in the State Pharmacopoeia of the Russian Federation XIII edition. The constant increase in the range of immunobiological preparations shows the need for further research of preservatives as a part of their content, as well as for studying their properties, mechanism of action and combinations with other preservatives.

консерванты, тиомерсал, фенол, формальдегид, иммунобиологический лекарственный препарат, preservatives, thiomersal, phenol, formaldehyde, immunobiological preparation

1. European Pharmacopoeia. 8th ed. Available from: http//online.edqm.eu/entry.htm.

2. United States Pharmacopeia. 37th ed. 2014.

3. WHO Expert Committee on Biological Standardization. Good Manufacturing Practices for Biological Products. Technical Report Series № 822 Annex 1, WHO Geneva, 1992.

4. U.S. Code of Federal Regulations. Current Good Manufacturing Practice in Manufacturing, Processing, Packing or Holding of Drugs; General (Part 210), Food and Drug Administration, DHHS, 21 CFR CH.l, 4-1-95.

5. Sanitary rules SP 3.3.2.1288-02 «Production and control of medical immunobiological preparations to ensure their quality» (in Russian).

6. Sanitary rules SP 3.3.2.1288-03 «Good manufacturing practices MIBP» (in Russian).

7. The State Pharmacopoeia of USSR. 9th ed. Moscow: Meditsina; 1961 (in Russian).

8. The State Pharmacopoeia of USSR. 10th ed. Moscow: Meditsina; 1968 (in Russian).

9. Meshkova RA. Immunization Guide for Physicians. Moscow: Meditsina; 1998 (in Russian).

10. Vaccines and toxoids. Draft general pharmacopoeial article. Approved by protocol of the Board of the Ministry of Health of the Russian Federation on the State Pharmacopoeia of 28.01.2014 № 4 (in Russian).

11. Tuberculous recombinant allergen in the standard dilution. Draft pharmacopoeial article. Approved by protocol of the Board of the Ministry of Health of the Russian Federation on the State Pharmacopoeia of 25.02.2014 № 6 (in Russian).

12. The State Pharmacopoeia of USSR. 11th ed. V. 1, 2. Moscow: Meditsina; 1987, 1990 (in Russian).

13. WHO Manual of Laboratory Methods for Potency Testing of Vaccines used in the WHO Expanded Programme on Immunization. WHO/BLG/95.1.

14. United Nations Environment Programme. The Intergovernmental Negotiating Committee for the preparation of a legally binding global instrument on mercury. A brief overview of the information provided by governments on the use of mercury preservatives in medicine, including vaccines. The third session. Nairobi 31.10-4.11.2011.

15. WHO/VSQ/GEN/94.01-94.11 IARC. Monographs on the Evaluation of Carcinogenic Risks to Human. 2006. V. 88. Available from: http//monographs.iarc.fr.

16. UNEP DTIE Chemicals Branch and WHO Department of Food Safety, Zoonoses and Foodborne Diseases 2008. Guidance for identifying populations at risk from mercury exposure. Available from: http://www.who.int/entity/foodsafety/publications/chem/mercuryexposure.pdf.

17. Pertussis-diphtheria vaccine for tetanus adsorbed. Draft pharmacopoeial article. Approved by protocol of the Board of the Ministry of Health of the Russian Federation on the State Pharmacopoeia of 18.03.2014 № 7 (in Russian).

18. Flu vaccine inactivated. Draft pharmacopoeial article. Approved by protocol of the Board of the Ministry of Health of the Russian Federation on the State Pharmacopoeia of 25.02.2014 № 6 (in Russian).

19. Hepatitis B vaccine recombinant, yeast. Draft pharmacopoeial article. Approved by protocol of the Board of the Ministry of Health of the Russian Federation on the State Pharmacopoeia of 25.02.2014 № 6 (in Russian).

20. Methodical instructions for use of physical and chemical methods to control medical biologicals. Moscow; 1977 (in Russian).

21. Methodical instructions for use of physical and chemical methods to control medical biologicals. Moscow; 1982 (in Russian).

22. Kargina TM. Application of atomic absorption spectrometry with electrothermal atomizer for analysis of thimerosal in sorbed viral, bacterial vaccines and toxoids. Vaccinology–2006. Moscow; 2006 (in Russian).

23. Quantitative determination of thiomersal in immunobiological medicines. Draft general pharmacopoeial article. Approved by protocol of the Board of the Ministry of Health of the Russian Federation on the State Pharmacopoeia of 28.01.2014 № 4 (in Russian).

24. Methodical instructions 3.3.2.1886-04-М. Validation of methods to control chemical and physico-chemical indicators of the quality of medical immunobiological preparations: the organization, conduct and reporting of results (in Russian).

25. Monograph «Thimerosal». United States Pharmacopeia. USP 37–NF 32. 2014. Р. 4930–4931.

26. The register of registered drugs of FSBI «SCEMAP» [Electronic resource] (in Russian).

27. Volkova RA, Kargina TM. A method of determining the phenol allergens. Copyright certificate № 98940 of 03.20.1981 (in Russian).

28. Physico-chemical, chemical, physical and immunochemical methods to control medical immunobiological preparations. Pharmacopoeial article 42-3874-99. Moscow: Ministry of Health of the Russian Federation; 2000 (in Russian).

29. Quantitative determination of phenol spectrophotometrically in immunobiological medicines. Draft general pharmacopoeial article. Approved by protocol of the Board of the Ministry of Health of the Russian Federation on the State Pharmacopoeia of 28.01.2014 № 4 (in Russian).

30. Quantitative determination of formaldehyde in immunobiological medicines. Draft general pharmacopoeial article. Approved by protocol of the Board of the Ministry of Health of the Russian Federation on the State Pharmacopoeia of 28.01.2014 № 4 (in Russian).